These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 38095468)

  • 1. Analysis of antiviral drug properties of thymidine kinase of herpes B virus using recombinant herpes simplex virus 1.
    Nguyen PHA; Fukushi S; Yamada S; Harada S; Yoshikawa T; Kinoshita H; Kawahara M; Ogawa T; Ebihara H; Moi ML; Saijo M
    Microbiol Spectr; 2024 Jan; 12(1):e0309123. PubMed ID: 38095468
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sensitivity of monkey B virus (Cercopithecine herpesvirus 1) to antiviral drugs: role of thymidine kinase in antiviral activities of substrate analogs and acyclonucleosides.
    Focher F; Lossani A; Verri A; Spadari S; Maioli A; Gambino JJ; Wright GE; Eberle R; Black DH; Medveczky P; Medveczky M; Shugar D
    Antimicrob Agents Chemother; 2007 Jun; 51(6):2028-34. PubMed ID: 17438061
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combination of ganciclovir and trifluridine prevents drug-resistance emergence in HSV-1.
    Schalkwijk HH; Shewakramani NR; Das K; Andrei G; Snoeck R
    Antimicrob Agents Chemother; 2024 May; 68(5):e0011024. PubMed ID: 38619252
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differences in the Likelihood of Acyclovir Resistance-Associated Mutations in the Thymidine Kinase Genes of Herpes Simplex Virus 1 and Varicella-Zoster Virus.
    Fujii H; Harada S; Yoshikawa T; Yamada S; Omura N; Shibamura M; Inagaki T; Kato H; Fukushi S; Saijo M
    Antimicrob Agents Chemother; 2019 May; 63(5):. PubMed ID: 30858222
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The novel immunosuppressive agent mycophenolate mofetil markedly potentiates the antiherpesvirus activities of acyclovir, ganciclovir, and penciclovir in vitro and in vivo.
    Neyts J; Andrei G; De Clercq E
    Antimicrob Agents Chemother; 1998 Feb; 42(2):216-22. PubMed ID: 9527762
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of a HSV thymidine kinase stimulating substance, scopadulciol, in improving the efficacy of cancer gene therapy.
    Hayashi K; Lee JB; Maitani Y; Toyooka N; Nemoto H; Hayashi T
    J Gene Med; 2006 Aug; 8(8):1056-67. PubMed ID: 16779868
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acyclovir-resistant herpes simplex virus type 1 in intra-ocular fluid samples of herpetic uveitis patients.
    van Velzen M; Missotten T; van Loenen FB; Meesters RJ; Luider TM; Baarsma GS; Osterhaus AD; Verjans GM
    J Clin Virol; 2013 Jul; 57(3):215-21. PubMed ID: 23582986
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Construction of a herpes simplex virus/varicella-zoster virus (HSV/VZV) thymidine kinase recombinant with the pathogenic potential of HSV and a drug sensitivity profile resembling that of VZV.
    Bevilacqua F; Davis-Poynter N; Worrallo J; Gower D; Collins P; Darby G
    J Gen Virol; 1995 Aug; 76 ( Pt 8)():1927-35. PubMed ID: 7636473
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bone marrow transplantation in a child with Wiskott-Aldrich syndrome latently infected with acyclovir-resistant (ACV(r)) herpes simplex virus type 1: emergence of foscarnet-resistant virus originating from the ACV(r) virus.
    Saijo M; Yasuda Y; Yabe H; Kato S; Suzutani T; De Clercq E; Niikura M; Maeda A; Kurane I; Morikawa S
    J Med Virol; 2002 Sep; 68(1):99-104. PubMed ID: 12210436
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Adenovirus-mediated herpes simplex virus thymidine kinase gene transference and combined drug therapy leads to apoptosis of human epithelial ovarian cancer cells].
    Jiang J; Kong B; Jiang S
    Zhonghua Fu Chan Ke Za Zhi; 2000 Dec; 35(12):736-9. PubMed ID: 11286034
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Contribution of a combination of ponicidin and acyclovir/ganciclovir to the antitumor efficacy of the herpes simplex virus thymidine kinase gene therapy system.
    Hayashi K; Hayashi T; Sun HD; Takeda Y
    Hum Gene Ther; 2002 Feb; 13(3):415-23. PubMed ID: 11860708
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Potentiation of ganciclovir toxicity in the herpes simplex virus thymidine kinase/ganciclovir administration system by ponicidin.
    Hayashi K; Hayashi T; Sun HD; Takeda Y
    Cancer Gene Ther; 2000 Jan; 7(1):45-52. PubMed ID: 10678355
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of herpes simplex virus type 1 recombinant thymidine kinase and its application to a rapid antiviral sensitivity assay.
    Shiota T; Lixin W; Takayama-Ito M; Iizuka I; Ogata M; Tsuji M; Nishimura H; Taniguchi S; Morikawa S; Kurane I; Mizuguchi M; Saijo M
    Antiviral Res; 2011 Aug; 91(2):142-9. PubMed ID: 21669227
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nucleotide sequence of thymidine kinase gene of sequential acyclovir-resistant herpes simplex virus type 1 isolates recovered from a child with Wiskott-Aldrich syndrome: evidence for reactivation of acyclovir-resistant herpes simplex virus.
    Saijo M; Suzutani T; Itoh K; Hirano Y; Murono K; Nagamine M; Mizuta K; Niikura M; Morikawa S
    J Med Virol; 1999 Aug; 58(4):387-93. PubMed ID: 10421406
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of scopadulciol-related molecules for their stimulatory effect on the cytotoxicity of acyclovir and ganciclovir against Herpes simplex virus type 1 thymidine kinase gene-transfected HeLa cells.
    Hayashi K; Rahman SM; Ohno H; Tanaka T; Toyooka N; Nemoto H; Hayashi T
    Chem Pharm Bull (Tokyo); 2004 Aug; 52(8):1015-7. PubMed ID: 15305006
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CRISPR/Cas9-mediated genome editing of the thymidine kinase gene in a clinical HSV-1 isolate identifies F289S as novel acyclovir-resistant mutation.
    Zheng S; Verjans GMGM; Evers A; van den Wittenboer E; Tjhie JHT; Snoeck R; Wiertz EJHJ; Andrei G; van Kampen JJA; Lebbink RJ
    Antiviral Res; 2024 Aug; 228():105950. PubMed ID: 38944159
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phenotypic and genotypic acyclovir resistance surveillance of genital herpes simplex virus 2 in South Africa.
    Muller EE; Maseko DV; Kularatne RS
    Antiviral Res; 2022 Apr; 200():105277. PubMed ID: 35271913
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genotypic and phenotypic characterization of acyclovir-resistant herpes simplex viruses isolated from haematopoietic stem cell transplant recipients.
    Stránská R; van Loon AM; Polman M; Beersma MF; Bredius RG; Lankester AC; Meijer E; Schuurman R
    Antivir Ther; 2004 Aug; 9(4):565-75. PubMed ID: 15456088
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel resistance-associated mutations of thymidine kinase and DNA polymerase genes of herpes simplex virus type 1 and type 2.
    Sauerbrei A; Bohn K; Heim A; Hofmann J; Weissbrich B; Schnitzler P; Hoffmann D; Zell R; Jahn G; Wutzler P; Hamprecht K
    Antivir Ther; 2011; 16(8):1297-308. PubMed ID: 22155911
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intracellular uptake of thymidine and antiherpetic drugs for thymidine kinase-deficient mutants of herpes simplex virus type 1.
    Bae PK; Kim JH; Kim HS; Chung IK; Paik SG; Lee CK
    Antiviral Res; 2006 Jul; 70(3):93-104. PubMed ID: 16546268
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.